ADL 21294
Alternative Names: ADL 2-1294; Loperamide ophthalmic - Adolor; Loperamide topical - AdolorLatest Information Update: 02 Oct 2021
At a glance
- Originator University of California, San Diego
- Class Antidiarrhoeals; Piperidines
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Dental pain; Ocular pain; Pain; Pruritus
Most Recent Events
- 31 Aug 2007 Discontinued - Preclinical for Pain in USA (Intra-articular)
- 10 Jul 2006 No development reported - Preclinical for Pain in USA (Intra-articular)
- 26 Sep 2003 Discontinued - Phase-II for Ocular pain in USA (Ophthalmic)